Clinical trials
Early Onset Sepsis clinical trials
Below are recruiting early onset sepsis clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07610486RecruitingPhase 1/Phase 2
Optimizing Ampicillin Dosing for Preterm Infants
This study aims to find the best dose of ampicillin for premature babies in the NICU who are being treated for possible early infection. The goal is to improve treatment and reduce side effects.
Durham, North CarolinaAges birth–1 week - NCT07152106Recruiting
Amniotic fluid and the preterm baby's gut
This study looks at the fluid around your baby (amniotic fluid) and how it might affect your baby's gut health if they are born early. It may help doctors understand how to better care for preterm infants.
AmsterdamAges 16 years+ - NCT06845332Recruiting
Best treatment choices for newborns with suspected early infection
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
AlkmaarAges Up to 3 days - NCT07460349Recruiting
Extended interval gentamicin dosing in newborns
This study looks at spacing out doses of the antibiotic gentamicin for newborns up to 7 days old who need it. The goal is to make sure the dosing schedule works well and is safe for babies.
London, OntarioAges birth–1 week - NCT06076200Recruiting
How Piperacillin/Tazobactam works in pregnant women and newborns
This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.
JinanAges 18 years+ - NCT06100614Recruiting
Using a blood test to reduce antibiotics in preterm newborns
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
Amsterdam, North HollandAges Any age - NCT07109856Recruiting
A new tool to predict infection in newborns
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
Graz, StyriaAges birth–6 hours
Hear when a new Early Onset Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for early onset sepsis?
- Yes. Clin2 currently lists 7 recruiting early onset sepsis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a early onset sepsis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a early onset sepsis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.